Literature DB >> 25635488

Optimizing the dose of rifapentine to treat tuberculosis. It's elementary.

Michael Lauzardo1, David Ashkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25635488     DOI： 10.1164/rccm.201412-2257ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  2 in total

Review 1.  Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.

Authors:  Yuhui Xu; Jianan Wu; Sha Liao; Zhaogang Sun
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-10-03       Impact factor: 3.944

2.  Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis.

Authors:  Ya-Yen Yu; Shih-Ming Tsao; Wen-Ta Yang; Wei-Chang Huang; Ching-Hsiung Lin; Wei-Wen Chen; Shun-Fa Yang; Hui-Ling Chiou; Yi-Wen Huang
Journal:  Int J Environ Res Public Health       Date:  2019-12-27       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.